Parkinson's Disease

A team experimenting with Parkinson's disease treatments has demonstrated how implanting carefully cultivated stem cells into rats can bring about remarkable recovery from motor symptoms typical of the disease.

Scientists probing the biological underpinnings of Parkinson's disease have made an important discovery, shedding new light on the demise of cells that drives neurodegeneration linked to the condition.

New research has found genetically engineered bacteria may be an effective Parkinson’s disease treatment. Scientists engineered a bacteria to synthesize a consistent source of medicine inside a patient’s gut, and animal tests have shown it is effective.

Researchers have uncovered how a certain enzyme triggers the breakdown of nerve fibers in neurodegenerative diseases – and how to potentially switch it off. The find could lead to a new class of drugs that slows the progression of these disorders.

Researchers working with a remote population in the Amazon have found the group experiences extraordinarily low rates of dementia. The study follows on from prior findings that the same group displayed almost no cases of age-related heart disease.

By the time that Parkinson’s disease is causing observable symptoms, it's often advanced to the stage that it's difficult to treat. In an effort to detect the disease earlier, scientists have developed an "electronic nose" that sniffs it out.

Researchers at the University of Copenhagen have identified a specific set of neurons in the brainstem that, when stimulated by electric pulses, can help improve the mobility of patients with Parkinson’s disease.

For around a decade, scientists researching Parkinson's disease have been probing a pathway involved in the way brain cells process energy, and now a mystery around the role of a particular protein has been solved thanks to a new live action view.

Misfolding proteins are considered key players in the development of Parkinson's disease, and scientists at the University of Bath have now developed a promising new weapon against them in the form of finely engineered peptide.

A new study has opened up a promising pathway for Parkinson's treatment, pinpointing a protein that plays a regulatory role in the neurodegeneration associated with the condition, and showing how it can be inhibited to protect brain cells from damage.

Building on a growing body of evidence linking viral infections with neurodegenerative disease, a study has shown how molecules on the surfaces of viruses can promote the aggregation of toxic proteins seen with diseases such as Alzheimer’s and Parkinson’s.

Two new studies are building on a hypothesis that multiple sclerosis (MS) can be triggered by viral infections in a person’s teenage years. The research raises concerns the current COVID-19 pandemic could lead to a surge in MS cases in the future.